1. Share Talk
  2. Pharmaceutical


14Apr 2017

Onzima Ventures Plc (AIM:ONZ) Proposed Acquisition and Capital Raising

Following its announcement on 17 January 2017, Onzima Ventures Plc (“Onzima” or the “Company”), is pleased to announce the conditional acquisition of the remaining 51 per cent. of the issued shares of N4 Pharma Limited (“N4 Pharma”) which it does not already own (the “Acquisition”). Consideration for the Acquisition will be satisfied by the issue of 4,510,800 New Ordinary Shares and 4,591,400 Deferred Consideration Shares (post-Share Re-Organisation).

23Apr 2016

Amryt Pharma – Building a Specialty Pharma Business


Amryt Pharma was established as a platform to acquire, build, develop and commercialise a range of drugs targeted at niche, orphan diseases, thereby creating a Specialty Pharmaceutical business. The company has acquired two companies which have brought in two products, one with European regulatory approval, which it is looking to expand into more indications. The company is led by a strong management team with considerable pharmaceutical experience. Amryt has a market capitalisation of £50m which compares very favourably with peers developing similar orphan assets, suggesting there is solid upside potential.

Subscribe To Our Newsletter
Be the first to get latest updates and exclusive content straight to your email inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
Get the week’s best articles right in your inbox
Join 15K subscribers